Status:

Do Not Prescribe (DNP), Red

Decision Date:

December 2019

Comments

RED:

• NICE TA697: Andexanet alfa for reversing anti-coagulation from apixaban or rivaroxaban.  (Decision date - June 2021)

DO NOT PRESCRIBE (DNP):

• NICE TA1029: (Terminated appraisal) Andexanet alfa for reversing anticoagulation in people with intracranial haemorrhage (decision date Feb 2025)

 

Do Not Prescribe (DNP) Drug Classifications

• 6: Have NICE guidance that recommends they should not be used

Red Drug Classifications

• 4: Specifically designated as “hospital only” by product licence or by DH/NICE

search again